The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis

Published:2020-05 Issue: Volume:104 Page:104640
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Wang Bi-Cheng^ORCID,Cao Ru-Bo,Fu Chen,Chen Wang-Bing,Li Pin-Dong,Lin Guo-He,Qian Xiao-Jun,Li Yun-Tian,Liu Quentin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference29 articles.

1. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study

2. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial;Yang;Eur J Cancer,2019

3. Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trial;Li;Int J Cancer,2019

4. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: final results of 2 parallel phase 2 clinical trials;Kong;Cancer,2017

5. Management of nasopharyngeal carcinoma: current practice and future perspective;Lee;J Clin Oncol: Off J Am Soc Clin Oncol,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control “always” matter?;Oral Oncology;2024-05

2. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors;International Forum of Allergy & Rhinology;2024-01-02

3. Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis;BMC Cancer;2023-11-30

4. Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

5. Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial;The Lancet Regional Health - Western Pacific;2023-11